U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06236802) titled 'ProVIDE II Bridging Study' on Jan. 24.
Brief Summary: The purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to BPH.
Study Type: Interventional
Condition: BPH With Symptomatic Lower Urinary Tract Symptoms
Intervention: Device: ProVee device
ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.
Other Names: * ProVee Expander
* ProVee
Recruitment Status: Not Yet Recruiting
Published by HT Digital Content Services with permission from Health Daily Dige...